News | Artificial Intelligence | August 06, 2018

New report notes that while improving technology is driving greater demand, regulatory and integration concerns still remain

Artificial Intelligence in Medical Imaging to Top $2 Billion by 2023

August 6, 2018 — The world market for machine learning in medical imaging is set for a period of robust growth and is forecast to top $2 billion by 2023, according to a new report from Signify Research. The artificial intelligence (AI) market comprises software for automated detection, quantification, decision support and diagnosis according to Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry.

Despite some of the earlier market hype, the report states it is becoming increasingly clear that AI will transform the diagnostic imaging industry, both in terms of enhanced productivity, increased diagnostic accuracy, more personalised treatment planning, and ultimately, improved clinical outcomes. AI will play a key role in enabling radiology departments to cope with the ever-increasing volume of diagnostic imaging procedures, despite the chronic shortage of radiologists in many countries.

Following the introduction of deep learning technology and affordable cloud computing, graphics processing units and storage, the pace of product development for AI-based medical image analysis tools is faster than ever before, Signify Research said. Not only is this leading to increased product availability from a wider selection of vendors, but AI-based tools are gradually becoming more accurate and sophisticated with added functionalities.

World Market for AI-Based Medical Image Analysis Software by Algorithm Type

The report notes that the interest and enthusiasm for AI in the radiologist community has notably increased over the last 12 to 18 months, and the discussion has moved on from AI as a threat, to how AI will augment radiologists. At the same time, there are emerging clinical applications where the use of AI has been shown to both improve clinical outcomes and deliver a return on investment for healthcare providers. Examples include software to detect and diagnose stroke, and analysis tools to measure blood flow in non-invasive coronary exams.

World Market for AI-Based Medical Image Analysis Software by Clinical Application

While the market holds great promise, it is still in the innovator and early adopter phase and there are several barriers to growth that need to be overcome before AI becomes mainstream in medical imaging, according to the report:

  1. The regulatory process remains challenging and there are few approved and fully commercialized products on the market, particularly deep learning-based products;

  2. More large-scale validation studies are needed to show the performance of deep learning algorithms in real-world clinical settings and boost radiologist confidence in AI;

  3. The results from AI-based image analysis tools need to be fully integrated into radiologists’ workflows and presented at the time of the primary read. Algorithm developers need to partner with imaging information technology (IT) vendors to ensure their solutions are tightly integrated; and

  4. Healthcare providers are reluctant to purchase AI tools from multiple software developers due to the vendor specific integration and implementation challenges and the administrative overhead. Algorithm developers need to establish effective routes to market, such as distribution deals with the established medical imaging vendors and the new breed of vendor-neutral AI platforms.

Up to now, the market has mainly been driven by the many start-ups and specialist software developers who are applying machine learning to medical imaging. The report notes, however, that major medical imaging vendors are now ramping up their AI activities. In the last year or so, Signify Research has also seen several of the world’s technology giants apply their AI expertise to medical imaging, most notably China’s Tencent and Alibaba. Over the coming years, the company says the combined research and development (R&D) firepower of the expanding ecosystem will knock down the remaining barriers, and radiologists will have a rapidly expanding array of AI-powered workflow and diagnostic tools at their disposal.

“Machine Learning in Medical Imaging – 2018 Edition” provides a data-centric and global outlook on the current and projected uptake of machine learning in medical imaging. The report blends primary data collected from in-depth interviews with healthcare professionals and technology vendors, to provide a balanced and objective view of the market.

Download the full report here.

For more information: www.signifyresearch.net

 

Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now